Charles River Laboratories (CRL) Jumped To A 6-Month High On Q4 Results

Charles River Laboratories (CRL) reported fourth quarter EPS of $1.21 Tuesday morning, up from $1.00 a year ago. Analysts expected EPS of $1.11. Full year EPS is expected to be between $5.00 and $5.10. The consensus estimate is for EPS of $5.05.

from RTT - Before the Bell http://ift.tt/2lPI2jc
via IFTTT